📊 MODD Key Takeaways
Is Modular Medical, Inc. (MODD) a Good Investment?
Modular Medical exhibits severe fundamental distress with massive operating losses (-$21.9M), negative cash flow generation (-$20.9M), and profitability margins in the millions of percent negative range. The company is burning cash while generating minimal revenue, indicating fundamental business model dysfunction rather than temporary operational challenges.
Fundamentals indicate a pre-revenue medical device company with extreme operating losses, zero gross margin, and deeply negative ROE/ROA. With only $2.9M in cash against -$17.9M operating cash burn, near-term external financing appears likely, increasing dilution risk. Until the company demonstrates meaningful revenue and margin traction, financial health remains weak.
Why Buy Modular Medical, Inc. Stock? MODD Key Strengths
- Positive current ratio of 1.59x indicates near-term liquidity capacity to cover obligations
- Zero debt burden eliminates leverage risk and solvency concerns
- Cash position of $2.9M provides runway for operations
- Debt-free capital structure
- Positive net equity and 1.6x current ratio
- EPS loss narrowed YoY
MODD Stock Risks: Modular Medical, Inc. Investment Risks
- Operating cash outflow of -$17.9M annually is unsustainable with current asset base; company will deplete cash within months at current burn rate
- Revenue of $16M against $21.9M operating losses indicates severe cost structure problem and inability to achieve profitability at current scale
- Negative free cash flow of -$20.9M combined with ongoing capital expenditure of $2.9M demonstrates capital is being destroyed rather than generated
- Extreme profitability metrics (operating margin -136731250%, net margin -136575000%) suggest systemic operational dysfunction
- Diluted EPS of -$0.37 shows per-share value destruction despite modest YoY improvement
- Severe cash burn vs. cash on hand implies short runway
- No meaningful revenue; 0% gross margin and large operating losses
- High dilution risk and continued value destruction (negative ROE/ROA)
Key Metrics to Watch
- Operating cash flow trajectory - critical survival metric given current negative -$17.9M burn rate
- Revenue growth sustainability and gross margin realization - minimal revenue with zero gross profit indicates fundamental product/pricing dysfunction
- Cash depletion timeline - with $2.9M cash and -$20.9M annual FCF burn, runway is approximately 1.7 months
- Operating cash flow (TTM) and cash balance/runway
- Revenue growth and gross margin trajectory
Modular Medical, Inc. (MODD) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Modular Medical, Inc. presents a mixed fundamental picture. Review the detailed metrics above to form your own investment thesis.
MODD Profit Margin, ROE & Profitability Analysis
MODD vs Healthcare Sector: How Modular Medical, Inc. Compares
How Modular Medical, Inc. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Modular Medical, Inc. Stock Overvalued? MODD Valuation Analysis 2026
Based on fundamental analysis, Modular Medical, Inc. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Modular Medical, Inc. Balance Sheet: MODD Debt, Cash & Liquidity
MODD Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Modular Medical, Inc.'s revenue has declined by 100% over the 5-year period, indicating business contraction. The most recent EPS of $-0.78 indicates the company is currently unprofitable.
MODD Revenue Growth, EPS Growth & YoY Performance
MODD Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2019 | N/A | -$258.8K | N/A |
| Q2 2019 | N/A | -$176.0K | N/A |
| Q1 2019 | N/A | -$38.7K | N/A |
| Q3 2018 | N/A | -$6.4K | N/A |
| Q2 2018 | N/A | -$1.1K | N/A |
| Q3 2017 | N/A | -$6.7K | N/A |
| Q2 2017 | N/A | -$6.9K | N/A |
| Q1 2017 | N/A | -$11.0K | N/A |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Modular Medical, Inc. Dividends, Buybacks & Capital Allocation
MODD SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Modular Medical, Inc. (CIK: 0001074871)
📋 Recent SEC Filings
❓ Frequently Asked Questions about MODD
What is the AI rating for MODD?
Modular Medical, Inc. (MODD) has a Combined AI Rating of STRONG SELL from Claude (STRONG SELL) and ChatGPT (STRONG SELL) with 88% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are MODD's key strengths?
Claude: Positive current ratio of 1.59x indicates near-term liquidity capacity to cover obligations. Zero debt burden eliminates leverage risk and solvency concerns. ChatGPT: Debt-free capital structure. Positive net equity and 1.6x current ratio.
What are the risks of investing in MODD?
Claude: Operating cash outflow of -$17.9M annually is unsustainable with current asset base; company will deplete cash within months at current burn rate. Revenue of $16M against $21.9M operating losses indicates severe cost structure problem and inability to achieve profitability at current scale. ChatGPT: Severe cash burn vs. cash on hand implies short runway. No meaningful revenue; 0% gross margin and large operating losses.
What is MODD's revenue and growth?
Modular Medical, Inc. reported revenue of $16.0.
Does MODD pay dividends?
Modular Medical, Inc. does not currently pay dividends.
Where can I find MODD SEC filings?
Official SEC filings for Modular Medical, Inc. (CIK: 0001074871) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is MODD's EPS?
Modular Medical, Inc. has a diluted EPS of $-0.37.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is MODD a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Modular Medical, Inc. has a STRONG SELL rating with 88% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is MODD stock overvalued or undervalued?
Valuation metrics for MODD: ROE of -371.6% (sector avg: 15%), net margin of -136,575,000.0% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy MODD stock in 2026?
Our dual AI analysis gives Modular Medical, Inc. a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is MODD's free cash flow?
Modular Medical, Inc.'s operating cash flow is $-17.9M, with capital expenditures of $2.9M. FCF margin is -130,406,250.0%.
How does MODD compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin -136,575,000.0% (avg: 12%), ROE -371.6% (avg: 15%), current ratio 1.59 (avg: 2).